Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Cancers announces selected third-party conferences. In case you would like to announce your own event on the Cancers website, please fill out the following form to apply for the announcement of a conference or other academic event (seminar, workshop).
Upcoming Partner Conferences (7)
16–20 February 2020 4th DNA Repair/Replication Structures and Cancer
Chaired by John Tainer (MD Anderson Cancer Centre), Tom Blundell (University of Cambridge) and Xiaodong Zhang (Imperial College London)
The conference will focus on structural and mechanistic insights into dynamic protein, chromatin, DNA and RNA complexes acting in DNA repair and its interface with DNA replication and transcription events relevant to cancer. Informative talks and poster sessions along with vibrant discussions will foster productive interactions and collaborations.
- Repair and replication complexes, structures and mechanisms
- RNA damage responses and actions in repair
- Mutational signatures, DNA repair, and cancer
- Intertwined interactions in transcription-replication-repair
- DNA damage signaling, pathway selection & cross-talk
- Targeting synthetic lethality and essentiality for damage responses
- Chromatin structures and dynamics in repair and cancer
- Epigenetics, DNA damage and repair
- PARP, PARG, and metabolic signaling
- Mitochondrial replication/repair and damage signaling
- DNA repair, apoptosis and cancer
18–20 February 2020 15th Annual Biomarkers Congress
The 15th Annual Biomarkers Series UK, 18 - 20 February 2020, Manchester, UK features 100+ presentations and provides a comprehensive look at biomarker research from early discovery through to the clinic across multiple therapeutic areas. For more information about the event and to join 450+ attendees.
24–27 February 2020 2nd Nuclear Receptors Conference
Chaired by Karen Knudson (Thomas Jefferson University), Charlotte Bevan (Imperial College London) and Wayne Tilley (University of Adelaide)
This unique meeting will bring together many of the leading figures in nuclear receptor research from across the globe, to discuss emerging roles and their implications for health and disease – and both human and drug development – in an intimate meeting that will generate meaningful idea exchange and interaction that will help to further shape this influential field.
- Further emerging roles for nuclear receptors in cancer
- Structural insights into nuclear receptor function and crosstalk
- Nuclear receptors’ role in epigenetic regulation and non coding RNA
- Nuclear receptors and DNA damage
- Nuclear receptors and cell cycle
- Nuclear receptors in metabolism/metabolic disease
- Nuclear receptors in the CNS
23–25 March 2020 Cancer Therapy 2020
We are pleased to announce the Cancer Therapy 2020 scientific meeting on March 23-25, 2020 at Melbourne. The meeting aims to bring together the pioneers in both basic and translational cancer research and cover the research studies discovering the genes affect cancer risk and the genomics; fundamentals of cancer cells and the hormone responses, cancer-controlling proteins, cell signaling and growth, novel diagnostic methods, new-generation molecular targeted therapies and immune treatments. Hope to see you at Cancer Therapy 2020 Melbourne on March 23-25, 2020.
Prism Scientific Services stepping ahead to create a platform to bring together the researchers from around the world fostering collaborations in the industry and the research community to focus their efforts on cancer research translation with an aim towards cancer free world.
26–27 May 2020 21st Annual Drug Discovery Summit and 8th Annual Drug Design & Medicinal Chemistry Congress
Join over 400 leaders, experts and scientists at the renowned R&D Series, helping to shape the future of drug discovery and development at Oxford Global’s 21st Annual Drug Discovery Summit and 8th Annual Drug Design & Medicinal Chemistry Congress, 26th – 27th May 2020, Berlin, Germany. The events bring together thought leaders to enable innovation in discovery on target, chemistry biology and medicinal chemistry.
Key opinion leaders joining our events include:
- Steve Rees,Vice President Discovery Biology, AstraZeneca R&D Biopharmaceuticals Discovery Sciences
- Ulrich A.K. Betz, Vice President Innovation, Department Head Future Insight, Merck KGaA
- Thorsten Thormann, Vice President, Research, LEO Pharma
- Alex Gouliaev, Vice President, Amgen
- Michael R. Myers, Senior Director, LRL - Due Diligence, Eli Lilly and Company
- Oliver Rausch, CSO, Storm Therapeutics
The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion. These events form part of the R&D Series EU and are co-located with our 2nd Annual Neuroscience in Discovery & Development Congresses.
View the agenda: https://bit.ly/35I18yz[email protected] or visit the website:
14–17 July 2020 Animal Models of Cancer Conference
This conference will focus on three major areas: First, it will present new approaches to generate precise and complex genetic alterations in mice and other animals to better "humanize" models and allow for in vivo studies of cancer gene function. Second, it will highlight studies to investigate fundamental mechanisms of cancer initiation and progression, including the cell of origin of tumors, their evolution, their metabolism, and their interactions with the immune system. Finally, the meeting will explore how genetically engineered animal models can help evaluate the efficacy of novel therapeutic approaches and to decipher mechanisms of therapeutic resistance.
- New technologies for cancer modelling
- Modeling pre-cancers and tumor initiation
- Cancer metabolism
- Cancer/immune interactions and tumor microenvironment
- Preclinical trials and resistance
5–8 October 2020 3rd Chromosomal Instability as a Driver of Human Disease Conference
Chaired by Ian Hickson (University of Copenhagen) and Oscar Fernandez-Capetillo (Karolinska Institutet)
Chromosome instability is involved in several human diseases and is a feature of natural ageing. This conference will bridge fundamental studies on the mechanisms by which cells maintain genome stability with applications of these studies aimed at the development of new therapies. Hence, the conference will bridge basic biology and clinical applications in this rapidly advancing field. Attendees should be able to obtain a full picture of the current status of the field, as well as to interact with prominent research leaders driving the clinical application of the latest research.
This conference is a continuation of the DNA Replication as a Source of DNA Damage series.